lung cancer
Conditions
Interventions
experimental group:None
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Voluntary consent and signing of the informed consent form; 2.Initial lung imaging examination revealing pulmonary nodules with lesions ranging from 6 to 30mm; 3.Age between 18 and 80 years (inclusive of 18 and 80 years); 4.Complete information regarding the location and pathological type of the pulmonary nodules; 5.Ability to obtain tissue samples or peripheral blood samples; 6.The patient agrees to be enrolled and provide postoperative follow-up information;
Exclusion criteria
Exclusion criteria: 1.Presence of other malignancies; 2.Pregnant or breastfeeding women, or other patients unsuitable for participation in the study; 3.Patients who have received chemotherapy, targeted therapy, immunotherapy, or lung surgery for lung cancer; 4.Patients who have previously undergone organ transplantation, hematopoietic stem cell transplantation, or blood transfusion within the last three months; 5.Unable to obtain tissue or cytological pathological diagnostic results; 6.Other reasons deemed by the researchers as unsuitable for clinical trial participation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung nodule size; | — |
Countries
China
Contacts
Public ContactChao Chen
Peking University Shenzhen Hospital
Outcome results
None listed